Novo Nordisk's Wegovy Oral Treatment Sales Surge in First Week
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 16 2026
0mins
Source: CNBC
- Strong Oral Treatment Sales: Novo Nordisk's Wegovy oral weight loss treatment saw about 1.3% of prescriptions in its first week, leading to a stock price increase of over 4%, indicating strong market demand that could underpin future revenue growth.
- Disappointing Regional Bank Earnings: Regions Financial reported fourth-quarter earnings of 57 cents per share, falling short of the 61 cents forecasted by analysts, resulting in a nearly 3% drop in stock price, reflecting profitability pressures and diminished market confidence.
- Energy Stocks Rally: Energy stocks surged, with GE Vernova and Bloom Energy both gaining around 6% as the Trump administration encourages tech companies to fund power plants, signaling optimism in utility infrastructure investments that may drive long-term growth for these companies.
- Biotech Stock Surge: ImmunityBio's stock jumped 28%, adding to a 30% rally from the previous session, as the company anticipates a 700% increase in full-year revenue for its bladder cancer drug Anktiva, showcasing strong market potential and investor confidence.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on AMCR
Wall Street analysts forecast AMCR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMCR is 10.72 USD with a low forecast of 9.00 USD and a high forecast of 13.60 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 44.190
Low
9.00
Averages
10.72
High
13.60
Current: 44.190
Low
9.00
Averages
10.72
High
13.60
About AMCR
Amcor plc is engaged in packaging solutions for consumer and healthcare products. The Company develops sustainable packaging in flexible and rigid formats across multiple materials. The Company operates through two segments: Flexibles and Rigid Packaging. The Flexibles segment consists of operations that manufacture flexible and film packaging in the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries. The Rigid Packaging segment consists of operations that manufacture rigid containers for a broad range of predominantly beverage and food products, including carbonated soft drinks, water, juices, sports drinks, milk-based beverages, spirits and wine, sauces, dressings, spreads and personal care items, and plastic caps for a wide variety of applications. The Company's subsidiaries include Berry Global Group Inc., Amcor Flexibles North America, Inc., Amcor UK Finance plc, Amcor Finance (USA), Inc., and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Amcor plc to Announce Q2 FY2026 Results on February 3, 2026
- Earnings Announcement: Amcor plc will release its fiscal 2026 second quarter and half-year results on February 3, 2026, after US market close, which is expected to significantly impact investor sentiment.
- Conference Call Timing: The company will hold a conference call at 5:30 PM US Eastern Time on February 3, 2026, to discuss the results, enhancing communication with investors.
- Global Participation: Investors can join the call using dial-in numbers from various countries, including the USA, Australia, the UK, and Hong Kong, ensuring convenient access for global stakeholders.
- Webcast Availability: A replay of the webcast will be available after the call, and investors can access supporting materials via the Investors section of Amcor's website, improving information transparency.
Continue Reading
Amcor plc to Announce Fiscal 2026 Q2 Results on February 3, 2026
- Earnings Announcement: Amcor plc will release its fiscal 2026 second quarter and half-year results after US market close on February 3, 2026, which is expected to significantly impact investor sentiment.
- Conference Call Details: The company will hold a conference call at 5:30 PM EST on February 3, 2026, providing dial-in numbers for global investors to participate and discuss the results.
- Webcast Availability: Investors can access the webcast and supporting materials via the Investors section of Amcor's website, ensuring transparency and enhancing engagement with stakeholders.
- Global Business Overview: Amcor operates in over 400 locations worldwide, generating $23 billion in annual sales, highlighting its leadership position and ongoing growth potential in the packaging industry.
Continue Reading